Raymond Wadlow, MD
Hematology & Oncology · Fairfax, VANPI 1548370612
Payments from drug & device makers
Across 180 payments — averaging $15,133 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$1.6M
- Eli Lilly$344K
- Syndax Pharmaceuticals, Inc.$305K
- Amgen$181K
- AbbVie$109K
- Exelixis Inc.$91K
- plus $88K from 19 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 45 | $1,606,089 |
| Eli Lilly | 2 | $343,536 |
| Syndax Pharmaceuticals, Inc. | 14 | $305,305 |
| Amgen | 17 | $180,980 |
| AbbVie | 33 | $109,038 |
| Exelixis Inc. | 13 | $90,977 |
| AstraZeneca | 3 | $23,556 |
| Astellas Pharma Global Development | 10 | $16,852 |
| Bayer | 5 | $11,600 |
| Array Biopharma Inc | 6 | $10,705 |
| Biontech SE | 1 | $10,500 |
| Incyte Corporation | 6 | $4,406 |
| Sirtex Medical Inc | 3 | $2,860 |
| Taiho Oncology, Inc. | 1 | $2,200 |
| Beone Medicines USA, Inc. | 1 | $1,950 |
| Halozyme Inc | 1 | $1,436 |
| Seagen Inc. | 1 | $1,225 |
| Johnson & Johnson | 9 | $271 |
| Pfizer | 3 | $107 |
| Astellas Pharma US Inc | 1 | $93 |
| GSK | 1 | $67 |
| Exact Sciences | 1 | $55 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
How this compares
$2,723,861 in reported general payments places this provider in the 95th percentile of 293 hematology & oncology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Fairfax
- Sekwon JangFairfax$11.8M
- Mohamad SalkeniFairfax$2M
- Nicholas RobertFairfax$951K
- Timothy McCarthyFairfax$862K
- Dipti Patel-DonnellyFairfax$754K
- William ErshlerFairfax$485K
- Chao YinFairfax$428K
- Daniel ChongFairfax$288K
- Gregory OrloffFairfax$269K
- Craig PortellCharlottesville$12.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.